# US 2026/0083677 A1 · Active ingredient containing stabilised solid medicinal forms and methods for the production thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083677 A1
- Document ID: US20260083677A1
- Status: Published application
- Kind: A1
- Application number: 19/190,525
- Filed: 2025-04-25
- Published: 2026-03-26
- Earliest claimed: 2006-09-25
- Assignees: Astellas Pharma Inc.
- Applicants: Astellas Pharma Inc.
- Inventors: Peter GRUBER; Dirk SPICKERMANN
- Web page: https://patentgrep.com/patent/US20260083677A1

## CPC

- A61K 9/2009: {Inorganic compounds}
- A61K 9/1611: {Inorganic compounds}
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to solid medicinal forms containing at least one active ingredient and at least one pharmaceutically compatible, water soluble drying agent which is selected from the group consisting of trimagnesium dicitrate and/or calcium chloride, the solid medicinal form having a drying loss of at most 6% and a relative equilibrium moisture content of 25% or less. The invention also relates to solid medicinal forms containing a moisture-sensitive active ingredient and trimagnesium dicitrate.

## Claims

### Claim 1

A non-effervescent solid medicinal form comprising:
(i) 5 to 50% by weight of a moisture-sensitive active ingredient, wherein said moisture-sensitive active ingredient is not trimagnesium dicitrate; and
(ii) 20-50% by weight of trimagnesium dicitrate acting as a drying agent that stabilizes the moisture-sensitive active ingredient against hydrolysis during storage;
wherein said solid medicinal form comprises a tablet or granule, further wherein said solid medicinal form exhibits a relative equilibrium moisture, measured at 25° C., of at most 20%.

### Claim 2 (depends on 1)

The non-effervescent solid medicinal form of claim 1, wherein said solid medicinal form further comprises 5 to 30% of weight of a microcrystalline cellulose.

### Claim 3 (depends on 1)

The non-effervescent solid medicinal form of claim 1, wherein said solid medicinal form exhibits a relative equilibrium moisture, measured at 25° C., of at most 15%.

### Claim 4 (depends on 1)

The non-effervescent solid medicinal form of claim 1, wherein said solid medicinal form exhibits a drying loss, measured at 120° C./30 min, of at most 6%.

### Claim 5 (depends on 1)

The non-effervescent solid medicinal form of claim 1, wherein said solid medicinal form is a tablet.

### Claim 6 (depends on 5)

The non-effervescent solid medicinal form of claim 5, wherein said tablet comprises at least one further excipient selected from the group consisting of lactose, mannitol, xylitol, lubricants, disintegrants, silica, and combinations thereof.

### Claim 7 (depends on 6)

The non-effervescent solid medicinal form of claim 6, wherein said lubricant is selected from magnesium stearate, stearic acid and combinations thereof.

### Claim 8 (depends on 6)

The non-effervescent solid medicinal form of claim 6, wherein said disintegrant is selected from the group consisting of such as cross-linked povidone, cross-linked carboxymethyl-cellulose, and combinations thereof.

### Claim 9 (depends on 5)

The non-effervescent solid medicinal form of claim 5, wherein said tablet is a film tablet.

### Claim 10 (depends on 1)

The non-effervescent solid medicinal form of claim 1, wherein said solid medicinal form is a granule.

### Claim 11 (depends on 1)

The non-effervescent solid medicinal form of claim 1, wherein said solid medicinal form is packaged together with an external drying agent in a tight packaging that is substantially impermeable to water.
